Delivery of a DNAzyme targeting c-myc to HT29 colon carcinoma cells using a gold nanoparticulate approach

Pharmazie

Volumn 63, Issue 3, 2008, Pages 221-225

  Tack, F ^a,b   Noppe, M ^b   Van Dijck, A ^b   Dekeyzer, N ^b   Van Der Leede, B J ^b   Bakker, A ^b   Wouters, W ^b   Janicot, M ^b   Brewster, Marcus ^b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c Pharmaceutical Sciences   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE SODIUM; COLLOIDAL GOLD; DNA; DNAZYME; ENZYME; FLUORESCEIN ISOTHIOCYANATE; GOLD DERIVATIVE; MESSENGER RNA; NANOPARTICLE; OLIGONUCLEOTIDE; POLYETHYLENEIMINE; POLYLYSINE; POVIDONE; TETRACHLOROAURIC ACID; TRANSFERRIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; COLON CARCINOMA; ELECTRICITY; FLUORESCENCE ACTIVATED CELL SORTING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYDROPHOBICITY; ONCOGENE C MYC; PH; POLYMERIZATION;

DNA, CATALYTIC; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GOLD COLLOID; HT29 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; PROTO-ONCOGENE PROTEINS C-MYC; TRANSFECTION;

EID: 41349096672     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.7325     Document Type: Article

References (30)

1. Achenbach J, Chiuman W, Cruz R, Li Y (2004) DNAzymes: from creation in vitro to applications in vivo. Curr Pharmaceut Biotech 5: 321-336.
2. Behr J (1994) Gene transfer with synthetic cationic amphiphiles: Prospects for gene delivery. Bioconjugate Chem. 5: 389-389.
3. Cairns M, Hopkins T, Witherington C, Wang L, Sun L (1999) Target site selection for an RNA-cleaving catalytic DNA. Nature Biotech 17: 480-486.
4. Daniel M, Astruc D (2004) Gold nanoparticles: assembly, supermolecular chemistry, quantum-size-related properties and applications towards biology, catalysis and nanotechnology. Chem Rev 104: 293-346.
5. Daniels T, Delgado T, Helguera G, Penichet M (2006) The transferring receptor part II: Targeted delivery of therapeutic agents into cancer cells. Clin Immunol 121: 159-176.
6. Dass C, Saravolac E, Li Y, Sun L (2002) Cellular uptake, distribution and stability of 10-23 deoxyribozymes. Antisense Nucleic Acid Drug Dev 12: 289-299.
7. Friedmann T (1997) Overcoming the obstacles to gene delivery. Scientific American June.
8. Haiss W, Thanh N, Aveyard J, Fernig D (2007) Determination of size and concentration of gold nanoparticles from UV-Vis spectra. Anal Chem 79: 4215-4221.
9. Isaka Y (2007) DNAzymes as potential therapeutic molecules. Curr Opin Molec Ther 9: 132-136.
10. Jaroff L (1999) Fixing the genes. Time Magazine Jan. 11.
11. Kelly R, Patterson C (2006) Slice me nice: DNAzyme get close to the heart. J Thromb Haemost 4: 1476-1478.
12. Khachigian L (2002) DNAzymes: cutting a path to a new class of therapeutics. Curr Opin Molec Therap 4: 119-121.
13. Kobayashi T, Ishida T, Okada Y, Ise S, Harashima H, Kiwada H (2007) Effect of transferring receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells. Int J Pharm 329: 94-102.
14. Noh S, Kim W, Kim J, Baek K, Oh Y (2007) Enhanced cellular delivery and transfection efficiency of plasmid DNA using positively charged biocompatible colloidal gold nanoparticles. Biochim Biophys Acta 1770: 747-752.
15. Oliver C (1999) Preparation of colloidal gold. Method Molec Biol 115: 327-330.
16. O'Sullivan M, Green J, Przybycien T (2003) Development of a novel gene delivery scaffold utilizing colloidal gold-polyethylenimine conjugates for DNA condensation. Gene Ther 10: 1882-1890.
17. Pun S, Bellocq N, Cheng J, Grubbs B, Jensen G, Davis M, Tack F, Brewster M, Janicot M, Janssens B, Floren W, Bakker A (2004) Biodistribution of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles. Cancer Biol Ther 3: 641-650.
18. Qian Z, Li H, Sun H, Ho K (2002) Targeted drug delivery via the transferring receptor-mediated endocytosis pathway. Pharmacol Rev 54: 561-587.
19. Ruponen M, Honkakoski P, Ronkko S, Pelkonen J, Tammi M, Urtti A (2003) Extracellular and intracellular barriers to non-viral gene delivery. J Control Release 93: 213-217.
20. Schmid G, Corain B (2003) Nanoparticulated gold: synthesis, electronics and reactivities. Eur J Inorg Chem 3089-3098.
21. Souid M, Iversen P (2005) Ribozymes, DNAzymes and small interfering RNAs as therapeutics. Curr Drug Targets 6: 647-653.
22. Sun L, Cairns M, Gerlach W, Witherington C, Wang L, King A (1999) Supression of smooth muscle cell proliferation by a c-myc RNA-cleaving deoxyribozyme. J Biol Chem 274: 17236-17241.
23. Sun L, Cairns M (2000) Design of DNAzymes that specifically target c-myc mRNA and their use for treating restenosis. World Patent WO 2000009672.
24. Tack F, Bakker A, Maes S, Dekeyser N, Bruining M, Elissen-Roman C, Janicot M, Brewster M, Janssen H, De Waal B, Franssen P, Lou X, Meijer E (2006a) Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes). J Drug Target 14: 69-86.
25. Tack F, Bakker A, Maes S, Dekeyser N, Brusining M, Elissen-Roman C, Janicot M, Hanssen H, De Waal B, Fransen P, Lou X, Meijer W, Arien T, Brewster M (2006b) Dendrimeric poly(propylene-imines) as effective delivery agents for DNAzymes: toxicity, in vitro transfection and in vivo delivery. J Control Release 116: E26-E28.
26. Tack F. Bakker A, Maes S, Dekeyser N, Brusining M, Elissen-Roman C, Janicot M, Hanssen H, De Waal B, Fransen P, Lou X, Meijer W, Arien T, Brewster M (2006c) Dendrimeric poly(propylene-iImines) as effective delivery agents for DNAzymes: Dendrimer synthesis, stability and oligonucleotide complexation. J Control Release 116: E24-E26.
27. Tamarkin L, Paciotti G (1999) Compositions and methods for targeted delivery of endogenous and exogenous bioactive agents. World Patent WO9924077.
28. Tamarkin L, Paciotti G (2002) Colloidal metal compositions and methods for drug targeting. World Patent WO2002087509.
29. Wagner E, Kloeckner J (2006) Gene delivery using polymer therapeutics. Adv Polymer Sci 192: 135-173.
30. Zauner W, Ogris M, Wagner E (1998) Polylysine-based transfection systems utilizing receptor-based delivery. Adv Drug Deliv Rev 30: 97-113.